![](https://cdn.sanity.io/images/0vv8moc6/targetedonc/916ab6b864508d729f01a98d36715ccaa0d89a0c-1920x1080.png?fit=crop&auto=format)
Lenvatinib and Pembrolizumab Combo Breaks New Ground in Non–Clear Cell RCC
Researchers have been able to better identify the different subtypes of non–clear cell renal cell carcinoma (nccRCC) to provide effective treatment, which was the focus of a presentation by Laurence Albiges, MD, PhD, during the 2024 Kidney Cancer Research …